
{"id":18738,"date":"2017-06-06T01:55:23","date_gmt":"2017-06-06T01:55:23","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/alectinib-frente-a-crizotinib-en-el-cancer-de-pulmon-no-microcitico-alk-positivo-no-tratado\/"},"modified":"2024-03-28T05:58:14","modified_gmt":"2024-03-28T05:58:14","slug":"alectinib-frente-a-crizotinib-en-el-cancer-de-pulmon-no-microcitico-alk-positivo-no-tratado","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/alectinib-frente-a-crizotinib-en-el-cancer-de-pulmon-no-microcitico-alk-positivo-no-tratado\/","title":{"rendered":"Alectinib frente a crizotinib en el c\u00e1ncer de pulm\u00f3n no microc\u00edtico ALK-positivo no tratado"},"content":{"rendered":"\n<p>Peters S<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Camidge DR<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Shaw AT<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Gadgeel S<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Ahn JS<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Kim DW<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Ou SI<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>P\u00e9rol M<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Dziadziuszko R<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Rosell R<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Zeaiter A<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Mitry E<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Golding S<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Balas B<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Noe J<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Morcos PN<span class=\"s1\"><\/span><span class=\"s2\">, <\/span>Mok T<span class=\"s1\"><\/span><span class=\"s2\">; <\/span>Investigadores del ensayo ALEX<span class=\"s2\">.<\/span><\/p>\n\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=alectinib%20versus%20crizotinib%20in%20untreated%20alk%20positive%20non%20small%20cell%20lung%20cancer.&amp;cmd=correctspelling\" target=\"_blank\" rel=\"noopener noreferrer\">Resumen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, P\u00e9rol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; Investigadores del ensayo ALEX. Resumen<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[218],"tags":[],"class_list":["post-18738","resources","type-resources","status-publish","hentry","category-hematologia-oncologia"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/18738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=18738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=18738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=18738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}